Jonathan Chung to Neoplasm Staging
This is a "connection" page, showing publications Jonathan Chung has written about Neoplasm Staging.
Connection Strength
0.243
-
Review of the international association for the study of lung cancer lymph node classification system: localization of lymph node stations on CT imaging. Clin Chest Med. 2013 Sep; 34(3):353-63.
Score: 0.079
-
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer. J Natl Cancer Inst. 2021 01 04; 113(1):48-53.
Score: 0.033
-
ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer. J Am Coll Radiol. 2019 May; 16(5S):S184-S195.
Score: 0.030
-
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. Gastroenterology. 2019 06; 156(8):2242-2253.e4.
Score: 0.029
-
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. J Clin Oncol. 2018 12 01; 36(34):3353-3360.
Score: 0.029
-
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib. J Thorac Oncol. 2017 03; 12(3):446-457.
Score: 0.025
-
Mediastinal lymph node staging: from noninvasive to surgical. AJR Am J Roentgenol. 2012 Jul; 199(1):W54-64.
Score: 0.018